BioSpace News Archive

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal’ or the “Company”) and PL Developments (PLD) today announced that they have commenced shipments of store brand equivalent Voltaren® Arthritis Pain Gel (diclofenac sodium topical gel, 1%) in 50, 100 and 150g laminate tubes following FDA clearance.

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that its abstract highlighting data from the Phase 3 program evaluating Sci-B-Vac®, the company’s 3-antigen prophylactic hepatitis B (HBV) vaccine, was accepted for e-poster presentation at the American Association for the Study of Liver Diseases

Proscia ® , a leading provider of digital and computational pathology solutions, has named pathology and laboratory management veteran Dr. Monica Santamaria-Fries to its executive team. In her role as Digital Transformation Officer, Dr. Santamaria-Fries will draw on her experi

Today, Infinity BiologiX (IBX), a leading next-generation central laboratory providing sample collection and processing, storage, analytical services, and scientific and technical support, announced two key new hires as part of its executive team. The expanded executive team now includes Craig

Find Rx Coverage Advisor builds on Walgreens efforts to support patients in maintaining affordable access to medications as health insurance shifts for many

Crown Bioscience today announces the appointment of Pam Shang as vice president for global quality. Mrs. Shang will be instrumental in further enhancing global quality across the company, leveraging her deep expertise in implementing quality systems for pharma and biotechnology clients including in GLP, GMP and other regulated environments. This press release features multimedia. View the full release here: https://www.busi

PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced that the first Turnkey Lighthouse lab in Newport, South Wales, is now processing COVID-19 testing samples as part of the Company’s collaboration with the Department of Health and Social Care (DHSC) in

This initial CEO Letter reflects a summary of major accomplishments since I began my tenure at Halberd Corporation.

Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its third-quarter 2020 financial results will be released on Monday, Nov. 2, 2020. Following the announcement, Horizon’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results. The live webcast and a replay may be accessed at http://ir.horizontherapeutics.com . Please connect to the Company’s website at le

New Data Evaluating KRYSTEXXA ® (pegloticase injection) With Concomitant Immunomodulation to Be Presented at the American College of Rheumatology Convergence 2020 -- Presentations will add to the growing body of evidence on the use of KRYSTEXXA with an immunomodulator to impact patient outcomes -- -- Oral presentation on Nov. 7 at 5:20 p.m. ET discussing data from RECIPE, the randomized controlled trial studying the concomitant use of KRYSTEXXA with t